KCell Biosciences
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $5.8M
Investors
- 5
About KCell Biosciences
Founded in 2021, and based in Busan, South Korea, KCell Biosciences operates as a biotechnology company that is involved in the research and production of vaccines with the goal of preventing disease-causing viruses like COVID. The company was established through a joint venture between Thousand Oaks Biopharmaceutical, a cell culture medium and CDMO (consignment development and manufacturing) company, and WSG, a company related to materials, parts, and equipment in the field of ASME BPE (bioprocess equipment). KCell Biosciences offers Cell Cultured Meat Production Solutions (CMS). Its full range of product portfolios and solutions includes CHO cell media, basal media, and feed. The product solutions and services extend to the contract development of cell lines and cell culture media, transient transfection of mammalian cells, and non-GMP production for biopharmaceutical companies that require cell culture bioprocesses. KCell Biosciences has also developed customized cell culture media for cell-cultured meat industries with a cost-effective solution.
Who invested in KCell Biosciences
5 investors across 1 round
See all investors in KCell Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 29, 2021
Amount
$5.8M
Investors
Questions about KCell Biosciences
Who invested in KCell Biosciences?
KCell Biosciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KCell Biosciences raised?
KCell Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KCell Biosciences last raise money?
KCell Biosciences's most recent round on record is a Series A, in Nov 2021.
What does KCell Biosciences do?
Founded in 2021, and based in Busan, South Korea, KCell Biosciences operates as a biotechnology company that is involved in the research and production of vaccines with the goal of preventing disease-causing viruses like COVID.
Where is KCell Biosciences headquartered?
KCell Biosciences is headquartered in South Korea.
Which VCs invest in companies like KCell Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at KCell Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like KCell Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.